GERRESHEIMER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.9 EUR | -1.10% |
|
-0.60% | +4.82% |
| Apr. 17 | Gerresheimer in demand after Stifel recommendation | DP |
| Apr. 15 | GERRESHEIMER AG : Deutsche Bank remains its Buy rating | ZD |
Presentation Operator MessageOperator (Operator)The conference is now being recorded. Welcome ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Calendar
2024-04-22
- PDA Parenteral Packaging Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
98.9
EUR
Average target price
132.4
EUR
Spread / Average Target
+33.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.82% | 3.68B | |
| -2.53% | 183B | |
| -3.52% | 105B | |
| +5.33% | 51.77B | |
| +16.43% | 47.29B | |
| -1.73% | 40.2B | |
| +5.66% | 27.62B | |
| -2.01% | 25.51B | |
| +9.84% | 24.73B | |
| -1.87% | 24.52B |
- Stock Market
- Equities
- GXI Stock
- News Gerresheimer AG
- Transcript : Gerresheimer AG, Q2 2022 Earnings Call, Jul 13, 2022
